Literature DB >> 34967064

Mandibular condyle morphology among patients with mucopolysaccharidosis: An observational study of panoramic radiographs.

Carmen Ulrike Schmid-Herrmann1, Nicole Maria Muschol2, Vera Ulrike Fuhrmann1, Anja Friederike Koehn2, Susanne Lezius3, Bärbel Kahl-Nieke1, Till Koehne4.   

Abstract

BACKGROUND: Mucopolysaccharidoses (MPS) are a group of rare metabolic diseases characterized by a wide spectrum of symptoms including progressive condylar resorption. AIM: The aim of this study was to quantify the severity of condylar involvement in MPS I individuals in comparison with a group of non-MPS individuals and to describe how condylar changes may vary among the different types of MPS.
DESIGN: Fifty panoramic radiographs of MPS patients (13.4 ± 6.2 years) with MPS I (n = 14), MPS II (n = 2), MPS IV (n = 8) and MPS VI (n = 2) were compared with forty panoramic radiographs of non-MPS individuals. The severity of condylar resorption was evaluated using a qualitative score (grades 0-3) and using the ratio of condylar height to ramus height (CH: RH).
RESULTS: All MPS I and VI individuals showed pronounced bilateral degenerative condylar resorption. In contrast, individuals with MPS II and IV exhibited heterogeneous findings. The quantification of condylar height to ramus height revealed that CH: RH was significantly decreased in MPS I as compared to that of non-MPS individuals (P < .001). In contrast, the CH: RH ratios of MPS II and IV showed great variability.
CONCLUSION: Mucopolysaccharidoses subtypes differ with regard to the severity of condylar resorption.
© 2021 The Authors. International Journal of Paediatric Dentistry published by BSPD, IAPD and John Wiley & Sons Ltd.

Entities:  

Keywords:  bone resorption; dental care for the disabled; lysosomal storage diseases; mandibular sondyle; mucopolysaccharidosis; osteoarthritis; rare disease

Mesh:

Year:  2022        PMID: 34967064     DOI: 10.1111/ipd.12952

Source DB:  PubMed          Journal:  Int J Paediatr Dent        ISSN: 0960-7439            Impact factor:   3.264


  1 in total

1.  Early enzyme replacement therapy prevents dental and craniofacial abnormalities in a mouse model of mucopolysaccharidosis type VI.

Authors:  Rohit Nagpal; Gina Georgi; Sarah Knauth; Carmen Schmid-Herrmann; Nicole Muschol; Thomas Braulke; Bärbel Kahl-Nieke; Michael Amling; Thorsten Schinke; Till Koehne; Julian Petersen
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.